Continuous Glucose Monitoring Devices Market To Reach US$16 Billion By 2034 As Connected Diabetes Care Adoption Accelerates
Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Continuous Glucose Monitoring Devices Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.
The global Continuous Glucose Monitoring Devices Market is valued at US$8.5 billion in 2026 and is projected to reach US$16 billion by 2034, expanding at a compound annual growth rate of 9.2%. Market growth is being supported by the rising prevalence of diabetes, increasing demand for real-time glucose insights, reduced reliance on fingerstick testing, and stronger clinical adoption of data-driven diabetes management.
Demand is increasingly influenced by factory-calibrated sensors, real-time mobile connectivity, extended sensor wear, improved accuracy, broader reimbursement coverage, and integration with insulin pumps and automated insulin delivery systems.
North America remains the largest regional market, supported by established reimbursement pathways, high diabetes technology adoption, and a strong presence of leading device manufacturers. Europe and Asia-Pacific are expected to record significant growth as healthcare systems modernize diabetes care, expand access to connected monitoring technologies, and strengthen remote patient management capabilities.
Key Continuous Glucose Monitoring Devices Market Insights
- Manufacturers are investing in longer sensor wear, improved comfort, stronger connectivity, enhanced accuracy, and more responsive customer support. Integration with insulin delivery devices, mobile applications, cloud-based platforms, and remote care systems is becoming a major competitive priority. Supply chain resilience, manufacturing consistency, sourcing stability, and dependable distribution are increasingly important to commercial performance. Device affordability, reimbursement differences, adhesive performance, wearability, and data ecosystem compatibility remain important market challenges. Established companies continue to leverage scale, clinical evidence, and brand recognition, while emerging participants compete through specialized products and faster innovation cycles. Regulatory requirements influence product development, market entry, procurement, data management, and commercialization strategies across regions. Mature markets favor advanced functionality and service integration, while developing markets place greater emphasis on affordability, accessibility, and practical deployment support.
Competitive Landscape
Competition in the Continuous Glucose Monitoring Devices Market is intensifying as glucose sensing companies, diabetes technology providers, insulin device manufacturers, pharmacies, and digital health businesses expand their connected care portfolios. Product launches, strategic partnerships, technology collaborations, acquisitions, investment activity, and regional expansion remain central to competitive positioning.
Companies covered in the market assessment include Abbott, Dexcom, Medtronic, Senseonics, Roche, Novo Nordisk, Insulet, Tandem Diabetes Care, Ypsomed, Ascensia Diabetes Care, Sinocare, MicroTech Medical, POCTech, Medtrum, i-SENS, Terumo, Acon Laboratories, Menarini, Biolinq, and GlucoTrack.
Strategic Market Intelligence and Forecasting
The Continuous Glucose Monitoring Devices Market report provides decision-ready analysis of market size, growth forecasts, technology trends, competitive positioning, supply-demand conditions, pricing, trade flows, and regional opportunities. Analytical coverage includes Porter's Five Forces, value chain mapping, scenario-based forecasting, company benchmarking, and assessment of market entry and expansion strategies.
The study evaluates how regulatory developments, reimbursement policies, macroeconomic conditions, sourcing risks, trade dependencies, and changing customer expectations may affect product availability, pricing, profitability, and investment priorities. It also identifies high-growth opportunities across product types, technologies, applications, end users, digital health integration, and insulin delivery ecosystems.
Geographic Coverage
- North America: United States, Canada, and Mexico Europe: Germany, United Kingdom, France, Italy, Spain, Netherlands, Switzerland, Poland, Sweden, and Russia Asia-Pacific: China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Vietnam Middle East and Africa: Saudi Arabia, South Africa, Iran, United Arab Emirates, and Egypt South and Central America: Brazil, Argentina, Chile, and Peru
Research Methodology
The market study combines primary interviews with participants across the Continuous Glucose Monitoring Devices value chain and secondary research from government publications, industry associations, trade databases, regulatory sources, and verified company disclosures. Data triangulation, statistical analysis, and scenario planning are used to support market sizing, segmentation, competitive analysis, and forecasts through 2034.
Key Questions Addressed
- What is the current and projected size of the Continuous Glucose Monitoring Devices Market? Which products, technologies, applications, and end-user segments offer the strongest growth potential? How are reimbursement policies and regulatory requirements affecting regional adoption? Which companies are strengthening their positions through innovation, partnerships, acquisitions, and expansion? How do supply chain conditions, trade flows, and pricing trends affect market accessibility and profitability? Which regional markets offer the most attractive entry, partnership, and investment opportunities?
Companies Featured
- Abbott Dexcom Medtronic Senseonics Roche Novo Nordisk Insulet Tandem Diabetes Care Ypsomed Ascensia Diabetes Care Sinocare MicroTech Medical POCTech Medtrum i-SENS Terumo Acon Laboratories Menarini Biolinq GlucoTrack
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment